Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Bladder Urothelial Carcinoma In Situ”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 9 of 0 results

Not applicableEnded earlyNCT02494635
What this trial is testing

Ultrasound and Biomarker Tests in Predicting Cancer Aggressiveness in Tissue Samples of Patients With Bladder Cancer

Who this might be right for
Bladder Papillary Urothelial CarcinomaStage 0a Bladder Urothelial CarcinomaStage 0is Bladder Urothelial Carcinoma+5 more
University of Southern California 4
Not applicableLooking for participantsNCT07614594
What this trial is testing

Non-invasive Urinary Genomics-Based Risk Assessment for Early Urothelial Carcinoma Diagnosis

Who this might be right for
Urothelial Carcinoma (UC)Upper Tract Urothelial CarcinomaUTUC+1 more
Henan Provincial People's Hospital 800
Large-scale testing (Phase 3)Study completedNCT00406068
What this trial is testing

Mycobacterial Cell Wall-DNA Complex in Treatment of BCG-refractory Patients With Non-muscle Invasive Bladder Cancer

Who this might be right for
Bladder Neoplasms
Bioniche Life Sciences Inc. 129
Early research (Phase 1)Ended earlyNCT03106610
What this trial is testing

Trial of Anti-PD-1 (Nivolumab) in Bladder Cancer Patients Recently Treated With Intravesical BCG Immunotherapy

Who this might be right for
Bladder Cancer
M.D. Anderson Cancer Center 1
Testing effectiveness (Phase 2)Study completedNCT00003129
What this trial is testing

Chemotherapy in Treating Patients With Early-Stage Bladder Cancer

Who this might be right for
Bladder Cancer
Eastern Cooperative Oncology Group 75
Testing effectiveness (Phase 2)Ended earlyNCT01625260
What this trial is testing

ALT-801 in Patients With Bacillus Calmette-Guerin (BCG) Failure Non-Muscle Invasive Bladder Cancer

Who this might be right for
Non-muscle Invasive Bladder Cancer
Altor BioScience 12
Large-scale testing (Phase 3)Ended earlyNCT01310803
What this trial is testing

Multi-center Study to Evaluate the Efficacy and Safety of Maintenance Therapy With Valrubicin Versus no Maintenance, in Subjects Treated With Valrubicin Induction for Carcinoma in Situ (CIS) of the Bladder

Who this might be right for
Carcinoma in SituTransitional Cell CarcinomaNon-muscle Invasive Bladder Cancer
Endo USA Inc., a Keenova Therapeutics Company 1
Testing effectiveness (Phase 2)Study completedNCT00462488
What this trial is testing

Study of Vicinium for Treating Patients With Non-Invasive Urothelial Carcinoma In Situ

Who this might be right for
Urinary Bladder CancerBladder CancerBladder Neoplasms+1 more
Sesen Bio, Inc. 46
Large-scale testing (Phase 3)Study completedNCT01442519
What this trial is testing

Sequential Bacillus Calmette-Guérin (BCG) and Electromotive Mitomycin-C Versus Bacillus Calmette-Guérin (BCG) Alone for High Risk Superficial Bladder Cancer

Who this might be right for
Bladder Cancer
University of Rome Tor Vergata 212